Your browser doesn't support javascript.
loading
Vici syndrome in Israel: Clinical and molecular insights.
Chorin, Odelia; Hirsch, Yoel; Rock, Rachel; Salzer Sheelo, Liat; Goldberg, Yael; Mandel, Hanna; Hershkovitz, Tova; Fleischer, Nicole; Greenbaum, Lior; Katz, Uriel; Barel, Ortal; Hamed, Nasrin; Ben-Zeev, Bruria; Greenberger, Shoshana; Nasser Samra, Nadra; Stern Zimmer, Michal; Raas-Rothschild, Annick; Pode-Shakked, Ben.
  • Chorin O; The Institute for Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
  • Hirsch Y; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
  • Rock R; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
  • Salzer Sheelo L; Dor Yeshorim, Committee for Prevention of Jewish Genetic Diseases, New York, NY, United States.
  • Goldberg Y; The Institute for Rare Diseases, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
  • Mandel H; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
  • Hershkovitz T; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
  • Fleischer N; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
  • Greenbaum L; Raphael Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
  • Katz U; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
  • Barel O; Raphael Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
  • Hamed N; Unit of Inherited Metabolic Disorders, Ziv Medical Center, Safed, Israel.
  • Ben-Zeev B; Institute of Human Genetics, Ziv Medical Center, Safed, Israel.
  • Greenberger S; The Genetics Institute, Rambam Health Care Campus, Haifa, Israel.
  • Nasser Samra N; Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
  • Stern Zimmer M; FDNA Inc, Boston, MA, United States.
  • Raas-Rothschild A; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel.
  • Pode-Shakked B; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.
Front Genet ; 13: 991721, 2022.
Article en En | MEDLINE | ID: mdl-36204321
ABSTRACT

Introduction:

Vici Syndrome is a rare, severe, neurodevelopmental/neurodegenerative disorder with multi-systemic manifestations presenting in infancy. It is mainly characterized by global developmental delay, seizures, agenesis of the corpus callosum, hair and skin hypopigmentation, bilateral cataract, and varying degrees of immunodeficiency, among other features. Vici Syndrome is caused by biallelic pathogenic variants in EPG5, resulting in impaired autophagy. Thus far, the condition has been reported in less than a hundred individuals. Objective and

Methods:

We aimed to characterize the clinical and molecular findings in individuals harboring biallelic EPG5 variants, recruited from four medical centers in Israel. Furthermore, we aimed to utilize a machine learning-based tool to assess facial features of Vici syndrome.

Results:

Eleven cases of Vici Syndrome from five unrelated families, one of which was diagnosed prenatally with subsequent termination of pregnancy, were recruited. A total of five disease causing variants were detected in EPG5 two novel c.2554-5A>G and c.1461delC; and 3 previously reported c.3447G>A, c.5993C>G, and c.1007A>G, the latter previously identified in several patients of Ashkenazi-Jewish (AJ) descent. Amongst 140,491 individuals screened by the Dor Yeshorim Program, we show that the c.1007A>G variant has an overall carrier frequency of 0.45% (1 in 224) among AJ individuals. Finally, based on two-dimensional facial photographs of individuals with Vici syndrome (n = 19), a composite facial mask was created using the DeepGestalt algorithm, illustrating facial features typical of this disorder.

Conclusion:

We report on ten children and one fetus from five unrelated families, affected with Vici syndrome, and describe prenatal and postnatal characteristics. Our findings contribute to the current knowledge regarding the molecular basis and phenotypic features of this rare syndrome. Additionally, the deep learning-based facial gestalt adds to the clinician's diagnostic toolbox and may aid in facilitating identification of affected individuals.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article